Type: Keyphrase
Name: Prostaglandin
First reported Oct 28 2014 - Updated Oct 28 2014 - 1 reports

Method for modulating stem cell growth

In one embodiment, provided is a composition including a prostaglandin compound for modulating stem cell proliferation and/or differentiation in a mammalian subject. In another embodiment, the instant application is directed to a composition which includes ... [Published Free Patents Online - Oct 28 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

Rapamycin-Insensitive Up-Regulation of Adipocyte Phospholipase A2 in Tuberous Sclerosis and Lymphangioleiomyomatosis

by Chenggang Li, Erik Zhang, Yang Sun, Po-Shun Lee, Yongzhong Zhan, Yanan Guo, Juan C. Osorio, Ivan O. Rosas, Kai-Feng Xu, David J. Kwiatkowski, Jane J. YuTuberous sclerosis syndrome (TSC) is an autosomal dominant tumor suppressor gene syndrome affecting ... [Published - Oct 27 2014]
First reported Oct 26 2014 - Updated Oct 26 2014 - 1 reports

Advice: the best way to avoid a hangover Sunday, 29. September 2013

What’s the best way to avoid a hangover?This is probably going to sound crazy, but it does work: before you start drinking, eat fatty foods and carbs. Fatty foods slow down the absorption of alcohol in to your body and help to lessen stomach irritation, ... [Published So - Oct 26 2014]
First reported Oct 25 2014 - Updated Oct 25 2014 - 1 reports

Prostaglandin D and leukotriene E synergize to stimulate diverse T2 functions and T2 cell/neutrophil crosstalk

Prostaglandin D2 (PGD2) and cysteinyl leukotrienes (cysLTs) are lipid mediators derived from mast cells, which activate TH2 cells. The combination of PGD2 and cysLTs (notably cysteinyl leukotriene E4 [LTE4]) enhances TH2 cytokine production. However, ... [Published Journal of Allergy and Clinical Immunology - Oct 25 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages

by Xuxia Sui, Yanmin Liu, Qi Li, Gefei Liu, Xuhong Song, Zhongjing Su, Xiaolan Chang, Yingbi Zhou, Bin Liang, Dongyang HuangEP3, one of four prostaglandin E2 (PGE2) receptors, is significantly lower in atherosclerotic plaques than in normal arteries and ... [Published - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Piperazine compound capable of inhibiting prostaglandin D synthase

This invention relates to a piperazine compound represented by Formula (I), wherein R1 is C1-6 alkyl;R2 is hydroxy, C1-6 alkyl that may have one or more substituents, —(C═O)—N(R3)(R4), or —(C═O)—OR5;R3 and R4 are the same or different, and each represents ... [Published Free Patents Online - Oct 21 2014]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

Your Period: Symptoms and Solutions

"But you typically only get cramps when you release an egg." That means you're likely to cramp less during the first few years of menstruation or if you're on birth control pills. If menstrual pain is cramping your style, you can take over-the-counter, ... [Published DailyMe.Com - Oct 19 2014]
First reported Oct 18 2014 - Updated Oct 18 2014 - 1 reports

New glaucoma medications relax trabecular meshwork, lower episcleral venous pressure

CHICAGO – IOP lowering through three different mechanisms comes together in one agent regardless of IOP baseline, a speaker said here at an Aerie Pharmaceuticals press briefing.Rhopressa relaxes the trabecular meshwork and increases outflow by inhibiting ... [Published Orthopedics Today - Oct 18 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

Ophthalmic solution

The present invention relates to an ophthalmic solution comprising a prostaglandin compound and viscosity-increasing compound. The ophthalmic solution of the invention is excellent in stability and can provide long lasting and increased effect when administrated ... [Published Free Patents Online - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

BioPharma Patents Quick Tips and News

THREE NEW CASES FROM THE FEDERAL CIRCUIT -UNEXPECTED RESULTS -1. In Allergan v. Apotex, 754 F.3d 952 (Fed. Gir. 2014). claims to method of growing eyelashes by administering a broad genus encompassing thousands of prostaglandin drugs were held invalid ... [Published JD Supra - Oct 02 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Prostaglandin D: A dominant mediator of aspirin-exacerbated respiratory disease

Aspirin desensitization followed by high-dose aspirin therapy is routinely performed for patients with aspirin-exacerbated respiratory disease (AERD). Little is known about the contributions of mediators other than cysteinyl leukotrienes to aspirin reactions ... [Published Journal of Allergy and Clinical Immunology - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Nitric oxide enhancing prostaglandin compounds, compositions and methods of use

The invention provides methods for treating ophthalmic disorders comprising at least one nitric oxide enhancing prostaglandin compound or a pharmaceutically acceptable salt thereof, and, optionally, at least one nitric oxide enhancing compound and/or ... [Published Free Patents Online - Sep 30 2014]


...According to news reporting originating from Maharashtra, India , by NewsRx correspondents, research stated, "MPGES-1 is inducible terminal synthase acting downstream of COX enzymes in arachidonic acid pathway, regulates the biosynthesis of pro-inflammatory prostaglandin PGE(2). Cardiovascular side effect of coxibs and NSAIDs, selective for COX-2 inhibition, stimulated interest in mPGES-1, a therapeutic target with potential to deliver safe and effective anti-inflammatory drugs."
"Another embodiment of the disclosure relates to a protein or peptide identified by the method. A further embodiment relates to or a protein or peptide selected from FIGS. 1A, 1B, 1C (SEQ ID Nos 22-84), Tables 1A, 1B, or Table 2 (SEQ ID Nos. 1-21)."

More Content

All (101) | News (94) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (3) | Press Releases (1)
sort by: Date | Relevance
Does Aspirin Prevent CVD and Cancer? Ignore the... [Published General Medicine eJournal - 20 hours ago]
GLENMARK PHARMACEUTICALS : Recent Findings from... [Published 4 Traders - Oct 29 2014]
Can Eyelash Enhancers be Used for Eyebrows? [Published LUUUX - Oct 29 2014]
Assessment of pharmacological activities of two... [Published 7thSpace - Oct 28 2014]
Cold and flu? challenge traditional thinking th... [Published Wholesale Manager - Oct 28 2014]
Method for modulating stem cell growth [Published Free Patents Online - Oct 28 2014]
Rapamycin-Insensitive Up-Regulation of Adipocyt... [Published - Oct 27 2014]
Use of Cartilage Derived From Murine Induced Pl... [Published Arthritis & Rheumatism - Oct 27 2014]
Advice: the best way to avoid a hangover Sunday... [Published So - Oct 26 2014]
Omega-3 Fatty Acids Increase Brain Volume [Published Pro Health Network - Oct 25 2014]
Prostaglandin D and leukotriene E synergize to ... [Published Journal of Allergy and Clinical Immunology - Oct 25 2014]
Kaposi's Sarcoma-Associated Herpesvirus Induces... [Published - Oct 24 2014]
Patent Issued for Method for Identifying Allerg... [Published 4 Traders - Oct 23 2014]
Cardiovascular risk a key issue for majority [Published Irish Medical Times - Oct 22 2014]
Santen Announces Positive Outcome of the Europe... [Published CNBC - Oct 22 2014]
Oxidized Low-Density Lipoprotein Suppresses Exp... [Published - Oct 21 2014]
Piperazine compound capable of inhibiting prost... [Published Free Patents Online - Oct 21 2014]
Prenatal diagnostics [Published Australian Doctor - Oct 21 2014]
Prostaglandin E2 Prevents Hyperosmolar-Induced ... [Published - Oct 20 2014]
Israeli trekkers return home as Nepalese rescue... [Published Israel Hayom - Oct 20 2014]
Your Period: Symptoms and Solutions [Published DailyMe.Com - Oct 19 2014]
New glaucoma medications relax trabecular meshw... [Published Orthopedics Today - Oct 18 2014]
Human medicines European public assessment repo... [Published European Medicines Agency - Oct 17 2014]
Medtronic : Patent Issued for Methods and Syste... [Published 4 Traders - Oct 16 2014]
Tpl2 in intestinal myofibroblasts in IBD [Immun... [Published PNAS - Oct 14 2014]
Sidebar: Micropulse Laser Trabeculoplasty [Published Cataract & Refractive Surgery Today - Oct 13 2014]
Ketoprofen Market: Global Industry Analysis and... [Published Good Day Sacramento - Oct 09 2014]
Period pains can be debilitating, but they can ... [Published Mail & Guardian Online - Oct 09 2014]
13 Household Uses for Cinnamon [Published Mother Earth Living - Oct 09 2014]
New Haven Pharmaceuticals Expands Management Te... [Published Yahoo! Finance - Oct 08 2014]
1 2 3 4
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
Allergan, Inc. v. Apotex, Inc. (Fed. Cir. 2014) [Published Patent Docs - Sep 03 2014]
By Michael Greenfield -- In a not particularly well-written opinion that breaks no new ground, the Federal Circuit considered a consolidated appeal of two patents directed to methods of promoting hair growth, including, in particular, eyelash hair growth ...
Brain Briefs: Vit D and Dementia, MS and Gut Bu... [Published - medical news plus CME for ph ... - Aug 08 2014]
(MedPage Today) -- Recent studies linked vitamin D deficiency with dementia risk and multiple sclerosis with intestinal microbiome activity, and a prostaglandin receptor may be a viable drug target in ALS. ...
BioLight Announces Issuance of U.S. Patent for ... [Published PBR - News - Jul 03 2014]
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the U.S. Patent and Trademark Office has issued patent number ...

Press Releases

sort by: Date | Relevance
OX-MPI project returned to Orexo [Published GlobeNewswire: Advertising News - Aug 06 2014]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.